- Home
- PBYI vs VRA Comparison
PBYI vs VRA Comparison
Compare PBYI & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- VRA
- Stock Information
- Founded
- PBYI 2010
- VRA 1982
- Country
- PBYI United States
- VRA United States
- Employees
- PBYI N/A
- VRA N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- VRA Apparel
- Sector
- PBYI Health Care
- VRA Consumer Discretionary
- Exchange
- PBYI Nasdaq
- VRA Nasdaq
- Market Cap
- PBYI 153.2M
- VRA 102.9M
- IPO Year
- PBYI N/A
- VRA 2010
- Fundamental
- Price
- PBYI $3.09
- VRA $3.72
- Analyst Decision
- PBYI Strong Buy
- VRA Strong Buy
- Analyst Count
- PBYI 1
- VRA 1
- Target Price
- PBYI $7.00
- VRA $5.50
- AVG Volume (30 Days)
- PBYI 754.5K
- VRA 363.1K
- Earning Date
- PBYI 02-27-2025
- VRA 12-11-2024
- Dividend Yield
- PBYI N/A
- VRA N/A
- EPS Growth
- PBYI 492.79
- VRA N/A
- EPS
- PBYI 0.47
- VRA N/A
- Revenue
- PBYI $243,569,000.00
- VRA $405,268,000.00
- Revenue This Year
- PBYI N/A
- VRA N/A
- Revenue Next Year
- PBYI N/A
- VRA $4.90
- P/E Ratio
- PBYI $6.63
- VRA N/A
- Revenue Growth
- PBYI 6.30
- VRA N/A
- 52 Week Low
- PBYI $2.23
- VRA $3.27
- 52 Week High
- PBYI $7.73
- VRA $8.32
- Technical
- Relative Strength Index (RSI)
- PBYI 49.17
- VRA 40.52
- Support Level
- PBYI $2.92
- VRA $3.46
- Resistance Level
- PBYI $4.06
- VRA $3.97
- Average True Range (ATR)
- PBYI 0.29
- VRA 0.22
- MACD
- PBYI 0.01
- VRA 0.05
- Stochastic Oscillator
- PBYI 27.07
- VRA 54.88
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.